"A group of legal experts are
pressing patent agencies, courts and policymakers to address the question as generative
A.I. seems on the brink of invading another uniquely human endeavor.
Generative artificial intelligence,
the technology engine powering the popular ChatGPT chatbot, seems to have a
limitless bag of tricks. It can produce on command everything from recipes and
vacation plans to computer code and molecules for new drugs.
But can A.I. invent?
Legal scholars, patent authorities
and even Congress have been pondering that question. The people who answer
“yes,” a small but growing number, are fighting a decidedly uphill battle in
challenging the deep-seated belief that only a human can invent.
Invention evokes images of giants
like Thomas Edison and eureka moments — “the flash of creative genius,” as the
Supreme Court justice William O. Douglas once put it.
But this is far more than a
philosophical debate about human versus machine intelligence. The role, and
legal status, of A.I. in invention also have implications for the future path
of innovation and global competitiveness, experts say.
The U.S. Patent and Trademark Office
has hosted two public meetings this year billed as A.I. Inventorship Listening
Sessions.
Last month, the Senate held a hearing on A.I. and patents. The witnesses
included representatives of big technology and pharmaceutical companies. Next
to them at the witness table was Dr. Ryan Abbott, a professor at the University
of Surrey School of Law in England, who founded the Artificial Inventor Project, a group of
intellectual property lawyers and an A.I. scientist.
The project has filed pro bono test
cases in the United States and more than a dozen other countries seeking legal
protection for A.I.-generated inventions.
“This is about getting the
incentives right for a new technological era,” said Dr. Abbott, who is also a
physician and teaches at the David Geffen School of Medicine at the University
of California, Los Angeles.
Rapidly advancing A.I., Dr. Abbott
contends, is very different from a traditional tool used in inventions — say, a
pencil or a microscope. Generative A.I. is also a new breed of computer
program. It is not confined to doing things it is specifically programmed to
do, he said, but produces unscripted results, as if creatively “stepping into
the shoes of a person.”
A central goal of Dr. Abbott’s project is to provoke and
promote discussion about artificial intelligence and invention. Without patent
protection, he said, A.I. innovations will be hidden in the murky realm of
trade secrets rather than disclosed in a public filing, slowing progress in the
field.
The Artificial Inventor Project,
said Mark Lemley, a professor at the Stanford Law School, “has made us confront
this hard problem and exposed the cracks in the system.”
But patent arbiters generally agree
on one thing: An inventor has to be human, at least under current standards.
The project has experienced mixed
results so far with patent authorities around the world. South Africa granted
it a patent for a heat-diffusing drink container that was generated by A.I.,
and most countries, including China, have not yet made a determination. In the
United States, Australia and Taiwan, its claims have been turned down.
After the U.S. patent office
rejected the project’s patent application — a decision upheld in a federal
appeals court — Lawrence Lessig, a professor at the Harvard Law School, joined a brief filed this
year with the Supreme Court.
In support of the project’s patent
claim, Mr. Lessig and his co-authors wrote that the federal appeals court’s
ruling “deprives an entire class of important and potentially lifesaving
patentable inventions of any protections” and “jeopardizes billions in current
and future investments” by undermining the incentive that patent protection
would provide.
The Supreme Court declined to hear
the case.
Many patents list several inventors,
and company employees are frequently named while the patent’s owner is their
employer. That suggests a middle ground for A.I. systems as a co-inventor,
credited and fully disclosed — a partner rather than a solo creator.
“That may end up being where we
land, but that’s a pretty big line to cross,” said Senator Chris Coons, the
chairman of the Judiciary subcommittee on intellectual property.
If granting A.I. inventor status is
a stretch today, stronger intellectual property protection for the
fast-evolving technology is not.
Mr. Coons, a Delaware Democrat, and
Senator Thom Tillis, a North Carolina Republican, introduced a bill last month
to clarify what kinds of innovations are eligible for patents. It is intended
as a legislative fix to the uncertainty raised by a series of Supreme Court
decisions. Patents on artificial intelligence, along with medical diagnostics
and biotechnology, would most likely become easier to obtain, legal experts
say.
The bill is not about artificial
intelligence specifically, but it “recognizes the direction of travel relative
to A.I.” toward stronger patent protection, said David Kappos, a former
director of the patent office and a partner at Cravath, Swaine & Moore.
At the Senate hearing, Dr. Abbott
made the case for A.I. invention, helped by an odd-looking drink container he
held up and described. It was created by an A.I. system trained on general
knowledge. It had no training in container design, and it was not asked to make
one.
The A.I. was built to combine simple
ideas and concepts into more complex ones and identify when one had a positive
outcome, a process repeated again and again. The resulting design was fed into
a 3-D printer. The container employs fractal geometry to improve heat transfer,
a kind of anti-Thermos. It could, for example, be used to quickly make iced
tea, boiled, steeped and refrigerated.
The container is easy to hold,
difficult to drink from and not headed for commercial production yet. But it is
certainly novel, and it is entirely the creation of an A.I. system without
human control.
The A.I. system was created by Stephen Thaler, who has conducted artificial
intelligence research and development for decades, at McDonnell Douglas and
later on his own. Dr. Abbott’s study of the A.I. field led him to Dr. Thaler,
who agreed to use his technology to generate a demonstration invention or two
for the Artificial Inventor Project.
Dr. Thaler’s patented system has
some ingredients similar to those in generative A.I. models like ChatGPT, and
others that are not. He describes his system as having the machine equivalent
of feelings. It becomes digitally excited, producing a surge of simulated
neurotransmitters, when it recognizes useful ideas, setting off “a ripening
process, and the most salient ideas survive.”
Dr. Thaler said the ability to
recognize and react in that way amounted to sentience, and his generative A.I.
system is called DABUS, for Device for the Autonomous Bootstrapping of Unified
Sentience.
He regards the reluctance of patent
authorities to recognize his system as an inventor as discrimination against a
creation-capable machine. “It’s speciesism to me,” he said.
But Dr. Abbott said, “That’s totally
irrelevant to the legal question.”
And that question will surely become
more pressing in time. “There is a universal consensus that A.I. will only get
better at this sort of thing,” Dr. Abbott said.”
Komentarų nėra:
Rašyti komentarą